Lupus: tinkering with haematopoietic stem cells

A New Combination of Idarubicin, Etoposide and Cytarabine in Untreated Acute Non-Lymphoblastic Leukemia.

Leukemia & lymphoma·2016

Patients with systemic lupus erythematosus (SLE) having developed malignant lymphomas. Complete remission of lymphoma following high-dose chemotherapy, but not of SLE.

Clinical and experimental rheumatology·2011

Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.

Autoimmunity·2006

Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation.

Lupus·2006

The promise of hematopoietic stem cell transplantation for autoimmune diseases.

Bone marrow transplantation·2003

Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect.

Bone marrow transplantation·2003

Gut microbiota dysbiosis and plasma lipidomic signatures in systemic lupus erythematosus.

Lupus·2026

Hematological involvement in juvenile-onset systemic lupus erythematosus: Clinical features and its impact on disease management.

Lupus·2026

Association between maternal autoimmune connective tissue disease and cardiac structure and function in the newborn.

Lupus·2026

Achievement of real-world adapted DORIS remission targets among patients with systemic lupus erythematosus initiating belimumab in the USA: A retrospective, observational, cohort study.

Lupus·2026

Stigma, discrimination-related events, and determinants among adult people living with systemic lupus erythematosus (SLE): Systematic review and indicator-level meta-analysis.

Lupus·2026

Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis.

Lupus·2026

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

Cancer immunology research·2026

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Practice Patterns in Inflammatory Bowel Disease in Pakistan: A National Survey of Physician Confidence and Therapeutic Strategies.

Inflammatory intestinal diseases·2026

Related Experiment Videos

Lupus: tinkering with haematopoietic stem cells

Related Concept Videos

A New Combination of Idarubicin, Etoposide and Cytarabine in Untreated Acute Non-Lymphoblastic Leukemia.

Patients with systemic lupus erythematosus (SLE) having developed malignant lymphomas. Complete remission of lymphoma following high-dose chemotherapy, but not of SLE.

Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.

Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation.

The promise of hematopoietic stem cell transplantation for autoimmune diseases.

Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect.

Gut microbiota dysbiosis and plasma lipidomic signatures in systemic lupus erythematosus.

Hematological involvement in juvenile-onset systemic lupus erythematosus: Clinical features and its impact on disease management.

Association between maternal autoimmune connective tissue disease and cardiac structure and function in the newborn.

Achievement of real-world adapted DORIS remission targets among patients with systemic lupus erythematosus initiating belimumab in the USA: A retrospective, observational, cohort study.

Stigma, discrimination-related events, and determinants among adult people living with systemic lupus erythematosus (SLE): Systematic review and indicator-level meta-analysis.

Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis.

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.

Practice Patterns in Inflammatory Bowel Disease in Pakistan: A National Survey of Physician Confidence and Therapeutic Strategies.

Related Experiment Videos

Lupus: tinkering with haematopoietic stem cells

Related Concept Videos

Related Articles